Frédéric is the CEO and co-founder of Immune Biosolutions, a biotech company driving the discovery of next-generation biologics through its proprietary Nebula chicken antibody platform. Winner of the 2013 National Grand Prize of the Québec Entrepreneurship Contest, Immune Biosolutions received several innovation prizes including the Spin Master innovation award, Devtech Bio 2013 and 2016. Immune Biosolutions was selected in 2016 by JLabs@Toronto, the newest Johnson&Johnson’s innovation incubators. Frédéric was recently elected on the Board of BioQuébec and is an active member of the Canadian Life Science community.
Frédéric holds a B.Sc. in Biotechnology from UQAM, a M.Sc. in Ecotoxicology from McGill University and a Ph.D. in Biochemistry from Université de Sherbrooke.